Advertisement
Advertisement
ELVN
Enliven Therapeutics, Inc. Common Stock
49.13
USDSponsored
+1.36
+2.85%
Jun 25, 11:32 UTC -4
Open
ELVN Earnings Reports
Positive Surprise Ratio
ELVN beat 17 of 24 last estimates.
71%
Next Report
Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.42
Implied change from Q1 26 (Revenue/ EPS)
--
/+10.53%
Implied change from Q2 25 (Revenue/ EPS)
--
/-14.29%
Enliven Therapeutics, Inc. Common Stock earnings per share and revenue
On May 07, 2026, ELVN reported earnings of -0.38 USD per share (EPS) for Q1 26, beating the estimate of -0.47 USD, resulting in a 19.49% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.14% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -0.42 USD, with revenue projected to reach -- USD, implying an increase of 10.53% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Enliven Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Enliven Therapeutics, Inc. Common Stock reported EPS of -$0.38, beating estimates by 19.49%, and revenue of $0.00, 0% as expectations.
How did the market react to Enliven Therapeutics, Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 1.14%, changed from $40.29 before the earnings release to $40.75 the day after.
When is Enliven Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 11, 2026.
What are the forecasts for Enliven Therapeutics, Inc. Common Stock's next earnings report?
Based on 7
analysts, Enliven Therapeutics, Inc. Common Stock is expected to report EPS of -$0.42 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement